Literature DB >> 438552

Seroepidemiology of infection with hepatitis A and B viruses in an isolated Pacific population.

I D Gust, N I Lehmann, M Dimitrakakis, P Zimmet.   

Abstract

To determine the prevalence of infection with hepatitis A virus and hepatitis B virus in an isolated population, samples of serum were collected from 574 healthy subjects living on the remote Pacific Island of Funafuti. Each specimen was tested for antibody to hepatitis A virus, hepatitis B surface antigen, and antibody to hepatitis B surface antigen by solid-phase radioimmunoassay. Overall, 79.8% of the population showed evidence of previous infection with hepatitis A virus, and 72.5% with hepatitis B virus; the high prevalence of antibody to both viruses in young adults suggested that the majority of infections were acquired in the first decade of life. Although it is known that hepatitis B virus maintains itself in isolated populations through a reservoir of chronic carriers, the reason for the persistently high rate of infection with hepatitis A virus is unknown.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438552     DOI: 10.1093/infdis/139.5.559

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

1.  Studies on antibody to hepatitis A virus in children and adults in London.

Authors:  V Damjanovic; M Ross; W Brumfitt
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 2.  Epidemiology of hepatitis B infection in the Western Pacific and South East Asia.

Authors:  I D Gust
Journal:  Gut       Date:  1996       Impact factor: 23.059

3.  The prevalence of hepatitis B infection amongst urban and rural populations in Western Samoa.

Authors:  I D Gust; M Dimitrakakis; S Faaiuso; J Ainuu; P Zimmet
Journal:  J Hyg (Lond)       Date:  1981-02

4.  A Serological Survey of Selected Papua New Guinea Blood Donors for Hepatitis B and Related Co-Infections.

Authors:  Francisca Varpit; Bruce Gummow
Journal:  Trop Med Infect Dis       Date:  2020-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.